Details of Disease
General Information of Disease (ID: DISDBRL6)
Disease Name | ALG3-congenital disorder of glycosylation | |||||
---|---|---|---|---|---|---|
Synonyms |
carbohydrate-deficient glycoprotein syndrome type IV (formerly); congenital disorder of glycosylation, type Id; carbohydrate-deficient glycoprotein syndrome, type IV, formerly; CDG 1D; CDGS4 (formerly); ALG3-CDG (CDG-Id); carbohydrate-deficient glycoprotein syndrome, type IV; CDGS, type IV, formerly; CDG Id; CDGS, type IV; ALG3-CDG; carbohydrate deficient glycoprotein syndrome type Id; CDGId; CDG-Id; ALG3-congenital disorder of glycosylation; mannosyltransferase 6 deficiency; CDG syndrome type Id; CDG1D; congenital disorder of glycosylation type Id; congenital disorder of glycosylation type 1d
|
|||||
Definition |
A form of congenital disorders of N-linked glycosylation characterized by severe neurological involvement, including hypotonia, developmental delay, intellectual disability, postnatal microcephaly, and progressive brain and cerebellar atrophy. Epilepsy with hypsarrythmia is frequently reported. Additional features that may be observed include failure to thrive, arthrogryposis multiplex congenita (AMC), vision impairment (optic atrophy, iris coloboma) and facial dysmorphism (hypertelorism with a broad nasal bridge, large and thick ears, thin lips, micrognathia). The disease is caused by loss of function mutations of the gene ALG3 (3q27.3).
|
|||||
Disease Hierarchy | ||||||
Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This Disease Is Related to 1 DME Molecule(s)
|
||||||||||||||||||||||||||||||
This Disease Is Related to 2 DOT Molecule(s)
|
||||||||||||||||||||||||||||||
References